Current applications and future development of magnetic resonance fingerprinting in diagnosis, characterization, and response monitoring in cancer
File(s) cancers-13-04742-v2-1.pdf (2.82 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Magnetic resonance imaging (MRI) has enabled non-invasive cancer diagnosis, monitoring, and management in common clinical settings. However, inadequate quantitative analyses in MRI continue to limit its full potential and these often have an impact on clinicians’ judgments. Magnetic resonance fingerprinting (MRF) has recently been introduced to acquire multiple quantitative parameters simultaneously in a reasonable timeframe. Initial retrospective studies have demonstrated the feasibility of using MRF for various cancer characterizations. Further trials with larger cohorts are still needed to explore the repeatability and reproducibility of the data acquired by MRF. At the moment, technical difficulties such as undesirable processing time or lack of motion robustness are limiting further implementations of MRF in clinical oncology. This review summarises the latest findings and technology developments for the use of MRF in cancer management and suggests possible future implications of MRF in characterizing tumour heterogeneity and response assessment.
Date Issued
2021-09-22
Date Acceptance
2021-09-16
Citation
Cancers, 2021, 13 (19), pp.1-20
ISSN
2072-6694
Publisher
MDPI AG
Start Page
1
End Page
20
Journal / Book Title
Cancers
Volume
13
Issue
19
Copyright Statement
© 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
License URL
Identifier
https://www.mdpi.com/2072-6694/13/19/4742
Subjects
1112 Oncology and Carcinogenesis
Publication Status
Published
Date Publish Online
2021-09-22
